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Background: Adverse drug events (ADEs) are a considerable cause of inhospital morbidity and mortality. Patient
flow differs substantially for surgical and nonsurgical patients: surgical patients are subjected to multiple medication
changes related to surgical intervention or postoperative care. The objective of this study is to systematically review
the occurrence and nature of ADEs in surgical patients. Also, a comparison with nonsurgical patients was made.
Methods: A search was conducted in Embase and Medline identifying studies that reported observational data on
the occurrence and nature of ADEs in surgical hospitalised adult patients. If sufficient data were available, the
occurrence of (preventable) ADEs was compared between surgical and nonsurgical patients.
Results: Six studies fulfilled the inclusion criteria. The occurrence of ADEs in surgical patients ranged from 2.0 to
27.7 per 100 admissions, from 4.7 to 8.9 per 1,000 patient days, or involved 8.9% of the patients. Proportions of
preventable ADEs in surgical patients were 18% and 54%, described in two studies. A head-to-head comparison of
surgical patients and nonsurgical patients was possible for five of six studies. The occurrence of ADEs in nonsurgical
patients was significantly higher than in surgical patients in three studies.
Conclusions: ADEs are a relevant problem in surgical patients and nonsurgical patients, with a high proportion of
preventable ADEs. The occurrence of ADEs appears to be higher in nonsurgical patients than in surgical patients.
However, studies lack details on the differences in nature of ADEs between hospital populations. To improve
medication safety this knowledge is essential.
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Adverse drug events (ADEs) are a major cause of mor-
bidity and mortality in hospital practice. An ADE is de-
fined as an injury resulting from medical interventions
related to a drug [1]. A preventable ADE is caused by an
error in the medication use process, such as a prescrib-
ing error [2]. The occurrence of ADEs in hospitalised
patients described in the literature varies between 2 and
52 ADEs per 100 admissions. An estimated 15% to 59%
of these ADEs are considered preventable [3]. Most re-
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reproduction in any medium, provided the oron ADEs in general medical care units, medical intensive
care units and paediatric units. However, not much specific
attention is given to ADEs in surgical patients. This is re-
markable since the hospitalisation process of surgical pa-
tients differs greatly from that of nonsurgical patients.
Surgical patients inherently have operative interven-
tions, and these interventions cause medication changes
[4]. A period of preoperative fasting is mandatory for
surgical patients in order to reduce the risk of pulmon-
ary aspiration during intubation. The period of fasting
usually affects preoperative medication intake, and the
route of administration frequently needs adjustment [5].
Surgical patients will also require (preoperative) antibiotics,
analgesics and muscle relaxants to which many ADEs can
be attributed [6,7]. In addition, half of the surgical patientsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the relative risk of a postoperative complication by 2.7
(95% CI 1.76-4.04) [8].
Taking these issues into account, it was expected that
surgical patients would have an increased risk for experi-
encing an ADE during their admission compared to
nonsurgical patients. If the occurrence and nature of
ADEs in surgical patients is specified, strategies can be
developed to prevent ADEs on surgical wards. There-
fore, the objective of this review was to determine the
occurrence and nature of ADEs in surgical patients. We
furthermore aimed to compare ADE occurrence in sur-
gical patients and nonsurgical patients.
Methods
Search strategy
Two reviewers (EBB, MdB) performed a computer-
assisted search of the medical databases Embase and
Medline (from 1980 to April 2011) with the aid of a clin-
ical librarian. A combined search term was constructed
with keywords in title or abstract, as outlined below. The
search was aimed at finding articles that reported obser-
vational data on ADEs in surgical hospitalised adult pa-
tients. There was no language restriction.
Keywords used to retrieve studies on adverse drug
events were: ‘adverse drug events’, ‘ADE’, ‘medication re-
lated problems’, ‘adverse drug reaction reporting system’
or ‘Drug therapy/adverse effects’. The terms ‘surgical’,
‘surgery’, ‘operation’, ‘preoperative’, ‘perioperative’ or ‘postop-
erative’ were added to specify surgical patients. The terms
‘hospitalized’ or ‘hospitalised’, ‘hospitalization’ or ‘hospital-
isation’, ‘hospital’ or ‘inpatients’ were included in order to
retrieve studies on hospitalised patients. The terms ‘fre-
quency’, ‘incidence’ or ‘epidemiology’ were used to retrieve
studies with epidemiological data.
To exclude children and incidents at presentation on
the emergency department, study titles containing the
terms ‘child’, ‘children’, ‘paediatrics’ or ‘emergency’ were
excluded. A manual cross-reference search of the eligible
papers was performed to identify other relevant articles.
Study selection and data collection
Two independent reviewers (EBB, MdB) selected the ar-
ticles based on titles and abstracts. Prospective studies
that evaluated ADEs in adult hospitalised surgical pa-
tients were included as well as studies from which the
data of ADEs in surgical patients could be extracted.
The ADE definition was not an inclusion criterion. Arti-
cles concerning ADEs in outpatients, children, or in pa-
tients at presentation to the emergency department were
excluded. Furthermore, studies that did not include sur-
gical patients or studies from which the data of surgical
patients could not be extracted were also excluded.
Studies that evaluated ADEs related to one specific drugwere not included in this review. If the title and abstract
justified inclusion, the full text was retrieved.
Each selected article was fully read by two authors
(EBB, MdB) and tested for the inclusion and exclusion
criteria. If the data of an article was also presented in an-
other previously selected article, the article was to be ex-
cluded. Disagreements about inclusion were discussed
with a third reviewer (JK) in a consensus meeting.
Summary measures and synthesis of results
Both reviewers independently extracted data using a stan-
dardized form. The primary endpoint was: the occurrence
and nature of ADEs, i.e. the causality, severity, preventabil-
ity, and accountable medication, in surgical patients. Add-
itionally, for preventable ADEs, caused by an error in the
medication use process, the reviewers aimed to assess the
medication error stages (e.g. ordering, transcribing, dis-
pensing, administrating or monitoring errors). The sec-
ondary endpoint was to compare the occurrence of
ADEs in surgical patients with nonsurgical patients. The
occurrence of ADEs was presented separately for surgical
and nonsurgical patients. Also an overall occurrence of
ADEs was presented, this number included the entire study
population of each study. The MINORS checklist devel-
oped by Slim et al. was used for the quality assessment [9].
This checklist was developed to determine the methodo-
logical quality of non-randomized studies, for use in com-
parative studies, i.e. comparing two or more groups, and
non-comparative studies. The MINORS checklist has been
shown to have good inter-reviewer agreement, high test–
retest reliability and good internal consistency [9]. It has
been externally validated for the ability to identify excellent
trials, [9] and has been previously applied in several sys-
tematic reviews [10,11]. This checklist consists of twelve
methodological items including assessment of the risk of
bias. For non-comparative studies eight items are scored,
and four additional items for comparative studies. The
items are scored on a 3-point scale ranging from 0 to 2;
the ideal total score for non-comparative studies is 16.
The occurrence of ADEs was described as number of
adverse drug events per 100 admissions, or, if the num-
ber of admissions was not available, the occurrence was
stated per 1,000 patient days or as a percentage of pa-
tients with an ADE.
The nature of the ADEs, i.e. causality, severity, prevent-
ability, medication error stage and accountable medication,
was described in total numbers and their percentage.
When the differentiation of medication accountable for
the ADEs included more than five medications, the top
five most frequent were shown. The nature was presented
for surgical and nonsurgical patients separately, if suffi-
cient data were available. If separate data could not be
extracted, the nature of the ADEs was presented for the
entire population (overall).
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If the number of patient days and the mean length of
hospital stay per patient could be extracted from the
studies, the number of admissions was estimated by div-
iding the patient days by the mean length of stay. These
data were used to calculate a mean occurrence of ADEs,
using a random effects model to account for heterogen-
eity among studies. This method provided rough figures,
but it gave a well founded impression of the difference
in occurrences of ADEs between surgical and nonsurgical
patients. Missing confidence intervals were calculated
manually. The statistical significance of a difference be-
tween point estimates was judged in two successive steps
by first examining whether either confidence interval
contained the other point estimate. Because this approach
tends to be anti-conservative, [12] we subsequently com-
pared the 83% confidence intervals of the seemingly signifi-
cantly different point estimates from the first step. In case
these confidence intervals overlapped, we decided for non-
significance at the 0.05 significance level [13]. The analyses
were performed using Microsoft Excel 2003.
Results
Study selection
The initial literature search strategy yielded 1,803 articles
(Figure 1). 1,737 articles were excluded after selection
based on title and abstracts and the full text of the
remaining 66 articles was retrieved. Consensus about in-
clusion of 63 articles was reached by two reviewers (EBB
and MdB). The remaining three articles were presented
to a third reviewer (JK), after which consensus betweenFigure 1 Flowchart article selection.the three reviewers was reached. Based on the full text,
six articles were included in this study [14-19]. Of the
remaining 60 articles, 56 were excluded for reasons
displayed in Figure 1. The other four articles reported
additional data about a patient population that was
already included in the review: these additional data
were linked to the initial report on that patient popula-
tion prior to the analysis [6,20-22].
Study characteristics
Study characteristics of the included studies are listed in
Table 1. The studies were published between 1991 and
2011; all studies were prospective observational studies
[14-19]. Based on the MINORS criteria, the quality of
the studies was good, and scored in the upper quartile of
the quality score range (13–15 points, possible max-
imum score was 16 points). Methods to detect ADEs
varied between the studies, but all studies used at least
chart review to identify ADEs. The chart review had
been performed by various types of healthcare providers:
nurses, nursing students, physicians or hospital pharma-
cists. As an additional identification method three of the
six studies also used voluntary incident reports by nurses
or pharmacists and daily direct observation of potential
drug-related events on the study wards [14,15,19]. One
study used direct observation without voluntary inci-
dence reports [16]. Two out of the six studies added a
computerized monitoring program including triggers to
recognize ADEs in combination with voluntary inci-
dence reports [17,18]. All studies considered the inci-
dence of ADEs to be the primary endpoint, four studies
also assessed the preventability of the ADEs.
Summary measures and synthesis of results
The occurrence of ADEs in surgical patients varied be-
tween 2.0 and 27.7 per 100 admissions, between 4.7 and
8.9 per 1,000 patient days, or involved 8.9% of the pa-
tients [14-19]. Two studies described the preventability
of the ADEs, 18% and 54% [15,16].
Five of six studies allowed comparison of the occur-
rence of ADEs between surgical and nonsurgical patients
[14-17,19]. In all five studies the occurrence of ADEs
was higher among the nonsurgical patients than among
the surgical patients. In four studies the point estimates
of the occurrence of ADEs in the surgical patients were
outside the interval estimate of the nonsurgical patients
and vice versa [14,16,17,19]. In three of these studies,
the 83% confidence intervals did not overlap, this result
was therefore considered significant [14,17,19]. In two
studies the difference was not considered significant
[15,16]. The occurrence of ADEs in nonsurgical patients
varied between 3.1 and 32.9 per 100 admissions and be-
tween 10.6 and 13 per 1,000 patient days, or involved
11.6% of the patients.
Table 1 Study characteristics




















Classen [17] USA 1 36,653 1989-1990 13 All patients admitted
to the hospital
SGC, MGC, OG Yes Yes No Yes Number and
characteristics
of ADEs
Bates [14] USA 1 420 1990 14 All patients admitted
to the study wards
SGC, MGC, OG,
CICU
Yes Yes Yes No Incidence and
preventability
of ADEs









Lazarus [18] USA 1 4,320 1996-1999 13 All trauma patients
admitted to the
hospital
Trauma Yes Yes No Yes Rate and nature
of ADEs




treatment > 48 hours
SGC, MGC No Yes Yes No Incidence and
preventability
of ADEs








SGC: surgical general care; MGC: medical general care; OG: obstetrics/gynaecology; ICU: intensive care unit; CICU: coronary ICU; SICU: surgical ICU; MICU: medical ICU. *MINORS was used for quality assessment,
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into surgical and nonsurgical subgroups. The prevent-
ability percentages differed between these two studies
[15,16]. The confidence intervals were manually calcu-
lated. In one study, the preventability percentage was
(not significantly) lower on the surgical ward (18%, 95%
CI 5.9-30.0) compared to the nonsurgical ward (28%,
95% CI 19.9-35.8) [15]. In the other study, the percentage
was (not significantly) higher on the surgical ward (54%,
95% CI 41.9-65.4) compared to the nonsurgical ward
(50%, 95% CI 39.7-60.3) [16]. Data on the nature of ADEs
could not be extracted for surgical and nonsurgical pa-
tients separately.
The overall occurrence of ADEs was calculated per
100 admissions [14-19]. In one study, [16] the number
of admissions was not provided so it was assumed that
the number of patients equalled the number of admis-
sions. The overall occurrence of ADEs ranged from 2.0-
29.2 per 100 admissions. Between 14% and 56% of the
ADEs were classified as preventable. When comparing
the results of surgical and nonsurgical patients with all
patients in Table 2, some questions may rise. The occur-
rence of all ADEs was the number of events described
in all patients of each study. Most studies included
other inpatients as well, such as obstetrics and gynae-
cology patients and intensive care patients. This ex-
plains why the occurrence of all ADEs was the same as,
or lower than the subgroups addressed in present re-
view [15,17]. The study by Berga Cullere et al. on the
other hand did only include surgical and nonsurgical
patients, and the occurrence of ADEs appears to be
higher in all patients than in the subgroups. This study
only provided percentages of patients with ADEs for
the subgroups, but the total number of all ADEs was
known in all patients. ADEs can occur more than once
in a patient, in this study, a total of 194 ADEs occurred
in 159 patients [16]. Therefore the ADE occurrence in
all patients was higher than the percentage of patients
with an ADE (Table 2).
Four studies established the overall severity of the
(preventable) ADEs and classified them as moderate or
significant in 57% to 85% of the ADEs, serious or severe
in 11% to 33%, and life-threatening in 4% to 12%; 1% to
2% of ADEs was lethal [15-17,19]. Three studies listed
the causality between the adverse event and the pre-
scribed drug. A heterogeneous pattern emerged: a rela-
tionship was deemed possible in 1% to 44%, probable or
likely in 38% to 56%, and definite in 1% to 62% of the
ADEs [14,16,17]. Analgesics (5% to 88%) and antibiotics
(2% to 36%) were most frequently accountable for ADEs.
According to two studies, errors in the medication use
process associated with preventable ADEs most fre-
quently occurred at the medication ordering (35% to
56%) and monitoring (55%) stages [15,19] (Table 3).Additional analysis
The mean occurrence of ADEs for surgical and non-
surgical patients was calculated per 100 admissions.
However in two studies, the number of admissions was
not provided [14,15]. Therefore, we used provisionally
calculated numbers of admissions to estimate a pooled
mean occurrence of ADEs per 100 admissions in these
studies. In one study the number of admissions was cal-
culated based on the length of hospital stay, which was
available for surgical and nonsurgical patients separately,
and the number of patient-days [15]. Another study did
not provide the length of hospital stay; the length of
hospital stay was estimated based on the total number of
admissions and patient days provided in the study [14].
Subsequently, the numbers of admissions on the surgical
and nonsurgical wards were approximated. These figures
are provided in italics in Table 2. One study did not pro-
vide the number of ADEs on the wards separately, but
presented the number of patients with an ADE, though
this number is probably an underestimation, it was used
in the calculation. Including the data of six studies, the
occurrence of ADEs in surgical patients was 8.5 ADEs
per 100 admissions (95% CI 5.4-11.6) [14-19]. For a par-
allel comparison, the occurrence of ADEs in surgical pa-
tients using the data of five studies (excluding the study
by Lazarus et al. [18]) was 10.0 ADEs per 100 admis-
sions (95% CI 1.3-18.6) [14-17,19]. The occurrence of
ADEs in nonsurgical patients, including data of five
studies, was 16.0 ADEs per 100 admissions (95% CI 3.4-
28.6) [14-17,19].
Discussion
With a structured literature search six articles were
found that provided information on the occurrence and
nature of ADEs in surgical patients. The reviewed articles
showed that ADEs frequently occur in surgical patients,
but were reported using various outcome measures, lim-
iting interstudy comparison and pooling of data. More-
over, apart from preventability, the studies did not
provide data that gave a clear insight into the nature of
ADEs in surgical patients. For five studies a comparison
of the occurrence of ADEs with nonsurgical patients was
possible. Head-to-head comparison showed a signifi-
cantly higher occurrence of ADEs in nonsurgical patients
compared to surgical patients in three studies, which
contrasts with the initial assumption of this review.
An estimated occurrence of ADEs of 8.5 per 100 surgi-
cal admissions, shows that medication related harm is a
current problem in surgical patients. The proportion of
preventable ADEs furthermore ranged from about a
quarter to more than half of all ADEs, which indicates a
serious health care problem that needs improvement.
Unfortunately, data on the nature of these ADEs were
lacking. Future research should focus more on a clear
Table 2 Occurrence and preventability of ADEs among surgical, nonsurgical and all inpatients
Population Data Unit Classen 1991 [17] Bates 1993 [14] Bates 1995 [15] Lazarus 2003 [18] Berga Cullere 2008 [16] Morimoto 2011 [19]
Surgical Records Admissions 23,458* 151‡ 493‡ - - 1,469
Patients - - - - 775 -
Patient-days - 1,066 4,339 - - -
No. ADEs ADEs 480 5 39* - - 407
Patients with ADE - - - - 69 -
Occurrence ADEs
(95% CI)
/100 admissions 2.0 (1.9-2.2)* 3.3 (0.5-6.2)‡ 7.9 (5.5-10.3)‡ - - 27.7 (25.4-30.0)
/100 patients - - - - 8.9 (6.9-10.9)* -
/1,000 patient-days - 4.7 (1.5-10.9)* 8.9 (6.1-11.7) - - -
Preventability ADEs - - 7/39 (18% (5.9-30.0))* - 37/69 (54% (41.9-65.4)
of the ADE patients)
-
Nonsurgical Records Admissions 8,064* 142‡ 527‡ - - 1,531
Patients - - - - 775 -
Patient-days - 1,003 11,499 - - -
No. ADEs ADEs 251 13 122* - - 504
Patients with ADE - - - - 90 -
Occurrence ADEs
(95% CI)
/100 admissions 3.1 (2.7-3.5)* 9.2 (4.4-13.9)‡ 23.1 (19.5-26.8)‡ - - 32.9 (30.6-35.3)
/100 patients - - - - 11.6 (9.4-13.9)* -
/1,000 patient-days - 13.0 (6.9-22.2)* 10.6 (8.7-12.4) - - -
Preventability ADEs - - 34/122 (28% (19.9-35.8))* - 45/90 (50% (39.7-60.3)
of the ADE patients)
-
Overall Records Admissions 36,653 420 4,031 4,320 † - 3,459
Patients - - - - 1,550 -
Patient-days - 2,967 21,412 - - -
No. ADEs ADEs 731 27 247 98† 194 1,010
Patients with ADE - - - - - -
Occurrence ADEs
(95% CI)
/100 admissions 2.0 (1.9-2.1)* 6.4 (4.1-8.8)* 6.1 (5.4-6.9) 2.3 (1.8-2.7)† - 29.2 (27.7-30.7)
/100 patients - - - - 12.5 (10.9-14.2)* -
/1,000 patient-days - - - - - -
Preventability ADEs - 15/27 (56%) 70/247 (28%) - 91/194 (47%) 141/1010 (14%)
*Calculated from rough data; ‡estimated based on rough data i.e. the numbers of admissions were calculated by dividing the patient-days by the length of hospital stay; 95% CI indicates the 95% confidence interval;




















Table 3 Nature of ADEs in all inpatients
Data Classen 1991 [17] Bates 1993 [14] Bates 1995 [15] Lazarus 2003 [18] Berga Cullere 2008 [16] Morimoto 2011 [19]
Severity ADEs 101 (14%) Severe - 3 (1%) Death - - 16 (2%) Death
600 (82%) Moderate 30 (12%) Life-threatening 49 (5%) Life-threatening
30 (4%) Mild 73 (30%) Serious 330 (33%) Serious
141 (57%) Significant 615 (61%) Significant
Severity Preventable ADEs - - 0 Death - 4 (4%) Life-threatening,
10 (11%) Severe
-
14 (20%) Life threatening 77 (85%) Moderate
30 (43%) Serious
26 (37%) Significant
Causality ADEs 450 (62%) Definite 56% Probable - - 2 (1%) Definite -
276 (38%) Probable 44% Possible † 98 (51%) Likely




227 (31%) Analgesics 25% Antibiotics 73 (30%) Analgesics 86 (88%) Analgesics 32 (16%) Antibiotics 365 (36%) Antibiotics
171 (23%) Antibiotics 15% Cardiac 59 (24%) Antibiotics 5 (5%) Anti-coagulants 18 (9%) Opiates 87 (9%) Sedatives
142 (19%) Cardiovascular 12% Anticoagulants 20 (8%) Sedatives 3 (3%) Antianxiety 11 (6%) Corticoids 78 (8%) NSAIDs
68 (9%) Anti-coagulants 48% Other † 18 (7%) Antineoplastics 2 (2%) Diuretics 10 (5%) Analgesics 73 (7%) Laxatives
18 (2%) Psychotherapeutic ¥ 9 (4%) Cardiovascular ¥ 2 (2%) Antibiotics 8 (4%) Diuretics ¥ 52 (5%) Antihypertensives ¥
Medication accountable for
Preventable ADEs
- - 20 (29%) Analgesics - - 26 (18%) Electrolytes
6 (9%) Antibiotics 25 (18%) NSAIDs
7 (10%) Sedatives 19 (13%) Antibiotics
5 (7%) Antipsychotic 9 (6%) Antihypertensives
4 (6%) Diabetes ¥ 6 (4%) Other analgesics ¥
Stage of medication errors
associated with Preventable
ADEs
- - 39 (56%) Ordering - - 45 (35%) Ordering
4 (6%) Transcription 0 Transcription
3 (4%) Dispensing 0 Dispensing
24 (34%) Administration 15 (11%) Administration
77 (55%) Monitoring
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understand the underlying causes of ADEs and develop
effective intervention strategies to reduce ADEs.
In five studies the occurrence of ADEs in surgical
and nonsurgical patients could be compared head to
head [14-17,19]. In all five studies that allowed com-
parison between surgical and nonsurgical patients, the
occurrence of ADEs was higher in nonsurgical patients
(significant in three out of five studies). The grounds of
these differences are hard to determine, since detailed
information on the surgical and nonsurgical patients
was not provided in the included studies. For example
information on known patient risk factors for ADEs
such as gender, age, kidney function and number of
comorbidities could clarify the variation in occurrence
of ADEs [7]. It was expected that the surgical interven-
tion, including the associated patient handovers and
medication changes, would have played a major role in
the occurrence of ADEs in surgical patients. Current
review does not provide information to justify whether
the hospitalisation process is a factor in the occurrence
of ADEs. From clinical perspective, it is likely that sur-
gical patients overall are less ill than nonsurgical pa-
tients, and the admission is usually planned. Moreover,
the key reason of admission for the surgical admission
is the surgical intervention, whereas the nonsurgical ad-
mission usually requires multiple medication interven-
tions to improve the clinical course of the disease.
The percentage of ADEs that was considered prevent-
able varied substantially between the studies and only
two studies assessed the preventability of ADEs in surgi-
cal and nonsurgical patient populations. Therefore, a
solid conclusion on this subject could not be reached. A
recent review on methods for assessing the preventability
of ADEs also described a large variation of preventability
percentages. They concluded that a large variation be-
tween studies was due to different instruments used for
assessing the preventability [23].
In studies including surgical patients, analgesics and
antibiotics were most frequently accountable for ADEs,
analgesics in 5-88% and antibiotics in 16-36% of the
ADEs [14-19]. Analgesics (pain management) and antibi-
otics (prophylaxis or treatment of wound infections) are
drugs typically related to surgery. The range in percent-
age occurrence is wide making interpretation for clinical
practice somewhat difficult. Nevertheless, these drug
types have been previously identified as high risk for
ADEs. A study on ADEs in 937 (surgical and nonsurgical)
hospital admissions described analgesics as most frequently
accountable for ADEs (26%), antibiotics accounted for 8%
of the ADEs [24]. Different numbers were reported in a
study determining the nature of medication related ad-
verse events, including 7889 (surgical and nonsurgical)
patients. In that study, anticoagulants were most frequentlyaccountable for the events (18%), analgesics in 5%, and
antibiotics in 13% of the events [25]. A systematic re-
view on preventable ADEs described overdosage as the
primary occurring error in analgesic use, resulting in
excessive sedation, hypothermia and respiratory dis-
tress. Symptoms of a preventable adverse outcome after
administration of antibiotics consist of an allergic reac-
tion or rash [26].
A strength of this review was the high methodological
quality of the included studies, tested with the MINORS
checklist. However, this systematic review has several
limitations as well. The main limitation was the hetero-
geneity in endpoints used in different studies, being ei-
ther number of ADEs per 100 admissions, or number of
ADEs per 1,000 patient days, or percentage of patients
with ADE. Due to this limitation, data could not be
pooled, which limits comparison of occurrence of ADEs
between surgical and nonsurgical patients. Although all
studies identified ADEs with (at least) chart review, the
occurrence of ADEs varied greatly (2–29 per 100 admis-
sions). A recent review on ADE assessment methods has
reported that direct observation identifies the most
events, and voluntary incident reports the least, but does
identify high severity events. Trigger tool methods are
regarded as the most efficient method [27]. In the present
review, occurrence is higher in studies that performed dir-
ect observation, [14-16,19] than in studies that did not
[17,18]. Furthermore, the chart reviewers in the various
studies had different backgrounds and experiences. The
reviewers consisted of nurses, nursing students, physicians
or hospital pharmacists. Considering these results, it can
be assumed that both the different ADE assessment
methods and the backgrounds of the reviewers are sig-
nificant drivers of the different (numbers of) ADEs iden-
tified. The causality assessment also varied greatly. This
might be due to the different instruments used to deter-
mine the causality, or to the different backgrounds of the
reviewers as previously described. Additionally, an aggre-
gated mean occurrence of ADEs per 100 admissions in
surgical and nonsurgical patients was calculated. But
since the outcome measures varied, the number of admis-
sions based on the length of hospital stay for two studies
had to be manually calculated. The results of these means
are therefore merely a rough estimation.
Secondly, a limited number of articles that fulfilled all
inclusion criteria were found. A logical explanation is the
limited amount of studies conducted on the occurrence
of ADEs in surgical patients. However, another possible
reason could be the search strategy used for this review.
The search was performed on Medline and Embase and
used explicit search terms to identify literature specific-
ally on ADEs in surgical patients. The latter might have
narrowed the view of all available studies. The studies
were published in a broad period of time, between 1991
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have been made in medical care. For example, in phar-
macological care, electronic prescribing has been intro-
duced; this method reduces the risk of ordering and
transcription errors and improves the detection of medi-
cation errors by hospital pharmacists.
The included studies described the definition of ADEs
in different words, but they all amounted to the same:
an injury resulting from medical interventions related
to a drug. However, some issues must be noted. In
three of the studies an ADE is defined as an event
caused by medication in a therapeutic dose, [16-18]
and one of these studies explicitly included omission
of a medication to the definition [16]. The other three
studies did not include dose restrictions to their def-
inition, it was therefore unclear if omission of a drug
was included [14,15,19].
Little information on the was provided in the studies
on the usage of medication safety interventions in the
study hospitals, such as a computerized ordering system,
was provided. We can therefore not explore if such in-
terventions may explain the differences in occurrence of
ADEs in the included studies. Customized information
technology can reduce the rate of medication errors in
hospitals [28]. Bar-code verification technology with an
electronic medication administration system (bar-code
eMAR), active participation of an on-ward hospital phar-
macy or CPOE are promising strategies [29-32]. No stud-
ies on the effect of customized information technology
on (preventable) ADEs have been performed in surgical
patients. The recent focus of improving safety in surgical
patients has been on reducing errors in the perioperative
pathway by a system approach using checklists [33]. For
example, a substantial improvement in surgical safety has
been achieved by the implementation of the comprehen-
sive checklist, the SURgical Patient Safety System (SUR-
PASS), which reduces the in-hospital mortality by half
(from 1.5 to 0.8 per cent) [34]. To provide optimal care,
it is important to gain more insight into the most com-
mon medication-related adverse events as well. By
implementing a targeted intervention strategy to prevent
ADEs, using a system approach focussing on the entire
surgical pathway, safety in surgical patients can be im-
proved even more [35].
Conclusions
The current findings show that ADEs are a relevant
problem in surgical and nonsurgical patients, with a high
proportion of preventable ADEs. However, studies lack
details on the differences in nature of ADEs between
surgical and nonsurgical patients. To improve medica-
tion safety this knowledge is essential. Focused strategies
aiming at the nature of ADEs in surgical and nonsurgical
patients are a likely solution to improve medication safety.For this, the nature of ADEs in various hospital popula-
tions needs to be elucidated.
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